Literature DB >> 19327951

State of the art: sedation concepts with volatile anesthetics in critically Ill patients.

Jens Soukup1, Katharina Schärff, Kristina Kubosch, Carsten Pohl, Michael Bomplitz, Jesco Kompardt.   

Abstract

The use of volatile anesthetics in the intensive care unit (ICU) has only been possible at great cost with the use of commercially available anesthesia systems. A new anesthetic-conserving device (AnaConDa) now facilitates, from a technical viewpoint, the routine use of volatile anesthetics in intensive care patients as part of prolonged sedation, using ICU ventilators. The volatile anesthetic is hereby applied continually via a syringe pump into a miniature vaporizer, which is integrated into the ventilator circuit in place of the usual respiratory filter. During expiration, the anesthetic exhaled by the patient enters the recirculation system, is predominantly stored in the active carbon layer of the anesthetic-conserving device, and redirected into the inspiratory air. At clinically relevant concentrations, more than 90% of the gas is recirculated in such a way. Aside from the possibility of using a central anesthetic gas scavenging system, the use of special passive residual gas filters, which can be connected to the expiratory outlet of the respirator machine, appears above all to be practical. The use of volatile anesthetics on the ICU could adopt a permanent position in various intensive care analgosedation concepts in future. It may be possible thereby to optimize the treatment process both in medical and economical terms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327951     DOI: 10.1016/j.jcrc.2009.01.003

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  20 in total

1.  Uncontrolled delivery of liquid volatile anaesthetic when using the anaesthetic conserving device.

Authors:  Igor Karnjuš; Dušan Mekiš; Miljenko Križmarić
Journal:  J Clin Monit Comput       Date:  2017-05-31       Impact factor: 2.502

2.  Isoflurane Ameliorates Acute Lung Injury by Preserving Epithelial Tight Junction Integrity.

Authors:  Joshua A Englert; Alvaro A Macias; Diana Amador-Munoz; Miguel Pinilla Vera; Colleen Isabelle; Jiazhen Guan; Brady Magaoay; Margarita Suarez Velandia; Anna Coronata; Awapuhi Lee; Laura E Fredenburgh; Deborah J Culley; Gregory Crosby; Rebecca M Baron
Journal:  Anesthesiology       Date:  2015-08       Impact factor: 7.892

Review 3.  Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.

Authors:  Derek J Roberts; Babar Haroon; Richard I Hall
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

4.  Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure.

Authors:  Julian Bösel; Jan C Purrucker; Frank Nowak; Julian Renzland; Petra Schiller; Eva Benveniste Pérez; Sven Poli; Benjamin Brunn; Werner Hacke; Thorsten Steiner
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

Review 5.  Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review.

Authors:  Jennifer Herzog-Niescery; Hans-Martin Seipp; Thomas Peter Weber; Martin Bellgardt
Journal:  J Clin Monit Comput       Date:  2017-08-31       Impact factor: 2.502

Review 6.  Waste anesthetic gas exposure and strategies for solution.

Authors:  Hai-Bo Deng; Feng-Xian Li; Ye-Hua Cai; Shi-Yuan Xu
Journal:  J Anesth       Date:  2018-02-05       Impact factor: 2.078

7.  The Effects of Acute Blood Loss for Diagnostic Bloodwork and Fluid Replacement in Clinically Ill Mice.

Authors:  James O Marx; JanLee A Jensen; Stacie Seelye; Raquel M Walton; F Claire Hankenson
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

8.  Isoflurane activates intestinal sphingosine kinase to protect against bilateral nephrectomy-induced liver and intestine dysfunction.

Authors:  Minjae Kim; Sang Won Park; Mihwa Kim; Vivette D D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-20

9.  Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury.

Authors:  Minjae Kim; Sang Won Park; Mihwa Kim; Vivette D D'Agati; H Thomas Lee
Journal:  Anesthesiology       Date:  2011-02       Impact factor: 7.892

10.  The Effect of Sevoflurane and Dexmedetomidine on Pulmonary Mechanics in ICU Patients.

Authors:  Mediha Türktan; Ersel Güleç; Zehra Hatipoğlu; Murat Türkeün Ilgınel; Dilek Özcengiz
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.